Clinical Trials Logo

Clinical Trial Summary

Pharmacotherapy and psychotherapy, effective management strategies for treatment-resistant depression are limited and yet to be developed. However, nursing interventions focusing on adherence enhancement, symptom reduction, and stress management may be strategic for a better disease management. This study aimed to define the rarely-studied concept of TRD under the cultural context of Taiwan and to identify new feasible and complementary treatment model from nursing perspectives. The project had established important basis on the descriptions of psychosocial features and need assessment of people with TRD over psychiatrist's validation. The findings also built up a cultural-specific non-pharmacological intervention module for effective TRD management in Taiwan. The nursing model of TRD management will further promote the development of integrative depression care in the future and complement current modalities, while providing important evidence-based information for future research and services.


Clinical Trial Description

The three-year pioneering project began with observing the psychosocial characteristics and demographic profile of a group of TRD cohort, followed by validating the cultural meanings and recovery constructs of TRD through professional and lay focus groups in the first year. In the second to third year, we examined the effectiveness of a 8-week, nurse-led psychosocial intervention with group approach in a randomized control trial (RCT) compared to the controls receiving usual care with three follow-ups. Detailed psychiatric assessment and study interviews have been performed at baseline, 3, 6, and 9 months after the intervention by a senior psychiatrist and a research assistant using standardized operation forms.Structured measurements have been utilized to collect primary outcome variables of psychological distress, suicide risk and resilience as well as secondary outcome measures of quality of life, community reintegration level, perceived satisfaction, and main clinical variables (e.g., treatment adherence, service use such as ER/OPD attendance or hospitalization days). The control group receives usual care of pharmacological therapy provided by the psychiatrists in the Psychiatric Department of the study hospital in northern Taiwan. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03329391
Study type Interventional
Source National Taiwan University Hospital
Contact
Status Completed
Phase N/A
Start date January 9, 2018
Completion date October 30, 2020

See also
  Status Clinical Trial Phase
Completed NCT02497287 - A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression Phase 3
Recruiting NCT03653858 - Efficacy Study of Deep Brain Stimulation in Patients With Treatment Resistant Major Depression N/A
Recruiting NCT02462551 - Focal Electrically Administered Seizure Therapy for the Treatment of Depression N/A
Recruiting NCT01868802 - Ketamine for Treatment-resistant Depression: A Multicentric Clinical Trial in Mexican Population Phase 2
Recruiting NCT05377177 - Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI N/A
Completed NCT05095792 - Effect of Ketamine on Neurological Activity as Measured by Electroencephalogram (EEG)
Active, not recruiting NCT03701724 - Cost-utility Analysis of Maintenance rTMS for Treatment-resistant Depression N/A
Recruiting NCT05800860 - A Trial of GH001 in Patients With Treatment-resistant Depression Phase 2
Completed NCT01945047 - Action of Ketamine in Treatment-Resistant Depression Phase 2/Phase 3
Recruiting NCT05045378 - Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression Phase 4
Completed NCT05454410 - Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD) Phase 2
Recruiting NCT05422417 - Dorsomedial Prefrontal Neuromodulation in Treatment-resistant Depression N/A
Recruiting NCT05842291 - pBFS Guided High-dose rTMS Therapy for Treatment-Resistant Depression N/A
Recruiting NCT04821271 - Antidepressant Effects of TS-161 in Treatment-Resistant Depression Phase 2
Active, not recruiting NCT04670081 - Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression Phase 2
Terminated NCT01598324 - Functional and Neurochemical Correlates of Treatment Response in Major Depressive Disorder N/A
Recruiting NCT05710237 - Does Psilocybin Require Psychedelic Effects to Treat Depression? Phase 2
Not yet recruiting NCT05661383 - Olfactory and Brain Stimulations in Treatment-resistant Depression N/A
Recruiting NCT05607654 - The Mechanisms of Underlying Accelerated Repetitive Transcranial Magnetic Stimulation for Treatment-resistant Depression N/A
Recruiting NCT05777876 - Early Identification of TRD and Construction and Clinical Validation of NTBS Precision Technology N/A